Search clinical trials for: XIENCE V

Total 1411 results

Abbott Medical Devices

Completed

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France (Far XIENCE V®)

Coronary Artery Disease

France
Odense University Hospital

Completed

The SOURT OUT IV TRIAL (SORT OUT IV)

Ischemic Heart Disease | Percutaneous Coronary Intervention | Coronary Atherosclerosis

Denmark
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (ESSENCE-DM)

Coronary Artery Disease

Korea, Republic of
Odense University Hospital

Completed

Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients (DIABEDES IV)

Diabetes Mellitus

Denmark
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Sino Medical Sciences Technology Inc.

Completed

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Coronary Artery Disease | Stable Angina Pectoris | Unstable Angina Pectoris

China
Abbott Medical Devices

Completed

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period (XERES)

Coronary Restenosis

France
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) (XVU-LTF)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
North Texas Veterans Healthcare System

Completed

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions (SOS-Xience V)

Coronary Artery Bypass | Atherosclerosis

United States
Cardiovascular Research Foundation, New York
Dickson Advanced Analytics Group

Completed

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents (ADAPT-DES)

Coronary Artery Disease

United States
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Abbott Medical Devices

Completed

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (ABSORB CHINA)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States
The Hospital District of Satakunta

Completed

Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography (BASE-OCT)

Acute Coronary Syndrome

Finland
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

Coronary Artery Disease

China
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Shandong Branden Med.Device Co.,Ltd
Fudan University

Unknown

Cordimax China Post Market Surveillance

Coronary Artery Stenosis

China
Deutsches Herzzentrum Muenchen

Unknown

Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World (ZEPPELIN)

Coronary Artery Disease

Germany
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis | Thrombosis (Stent Thrombosis)

China
Universitaire Ziekenhuizen KU Leuven

Withdrawn

COmplex BifuRcation Lesions: A Comparison Between the AXXESS Device and Culotte Stenting: An Optical Coherence Tomography (OCT) Study (COBRA)

Coronary Artery Stenosis

Belgium
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent (RESOLUTE-AC)

Coronary Artery Disease

Switzerland
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Coloplast A/S

Completed

Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy

Ileostomy - Stoma | Colostomy - Stoma

Denmark
Deutsches Herzzentrum Muenchen

Completed

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography (TEST-6-OCT)

Coronary Heart Disease

Germany
Foundation of Cardiovascular Research and Education...

Completed

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente (TWENTE)

Coronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
The Hospital District of Satakunta

Unknown

Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome (BASE-ACS)

Acute Coronary Syndrome

Finland
Korea University Anam Hospital
Korea University Guro Hospital; Yonsei University; Kyungpook National University... and other collaborators

Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial ) (Restenosis)

In-stent Arterial Restenosis

Korea, Republic of
The Hospital District of Satakunta

Completed

Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome (BASE-CFR)

Acute Coronary Syndrome

Finland
OrbusNeich
Genae

Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT (REMEDEE-OCT)

Coronary Artery Disease | Atherosclerosis | Acute Coronary Syndrome (ACS) | Myocardial Infarction (MI)

United Kingdom, Netherlands, Finland, Belgium, Switzerland
University of Jena
Boston Scientific Corporation; Abbott Medical Devices; B. Braun Melsungen AG

Completed

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents (OCTOPUS)

Stents | Neointimal Proliferation

Germany
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1) (XVU-Phase 1)

Coronary Artery Disease

United States
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Cilnidipine and Valsartan

Healthy

Korea, Republic of
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
Harbin Medical University

Unknown

Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography (NeoCover)

Acute Myocardial Infarction

China
Livzon Pharmaceutical Group Inc.

Active, not recruiting

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 (COVID-19)

COVID-19 Pandemic

China
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Patients With Coronary Artery Disease (CAD) (RACES)

Coronary Artery Disease | Coronary Atherosclerosis

Italy
Abbott Medical Devices

Terminated

SPIRIT Small Vessel Registry (SPIRIT SV)

Myocardial Ischemia | Coronary Artery Disease | Atherosclerosis

United States
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg (DESTINY)

Peripheral Vascular Disease | Critical Limb Ischemia

Belgium, France, Germany
The Royal Bournemouth Hospital

Completed

R-wave Optimisation in Cardiac Resynchronisation Therapy Study

Heart Failure, Systolic

United Kingdom
RWTH Aachen University

Terminated

Influence on Erythropoetin-level by Xenon (XEPO)

Healthy Volunteers

Germany
Inossia AB
Uppsala University; EIT Health

Recruiting

Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures (SOFTBONE)

Vertebral Compression Fracture

Spain, Germany, Canada, Poland
Abbott Medical Devices

Completed

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Coronary Artery Disease

United States
Immunitor LLC

Unknown

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer (GBM)

Glioblastoma Multiforme | Glioma of Brain

Mongolia
Spanish Society of Cardiology

Unknown

Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

Coronary Artery Disease

Spain

Search clinical trials for: XIENCE V

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations